The Latest
Phase 3 JAVELIN Ovarian Cancer Study Halted
FDA Places Clinical Hold on Venetoclax Trials for Multiple Myeloma
FDA Warns Company Selling Misbranded Drugs With False Claims
High Discordance Between LDL-C, Lp(a) Reduction in Response to Evolucumab
Oral Semaglutide NDAs Seeking T2D Indication, CV Risk Reduction
Analgesics in Pregnancy Do Not Seem to Cause Offspring Asthma
Volatile Anesthetics Do Not Reduce Deaths in Elective CABG
Favorable Outcomes Seen in Long Term for ALLR3 Trial
